Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - CAPITAL EXPENDITURES
Capital Expenditures BCRX - BioCryst Pharmaceuticals, Inc.
-2.17 M
LAST VALUE
4.66%
2 YEAR CAGR
-42.73%
5 YEAR CAGR
-53.42%
10 YEAR CAGR